Angle Regulatory News (AGL)

24 Sep 2009 07:40



ANGLE plc ("the Company")

Director's share purchase

ANGLE plc ("ANGLE"), the international venture management company focusing on the commercialisation of technology and the development of technology-based industry, announces that it has received notification from Andrew Newland, Chief Executive of ANGLE, regarding the purchase of ordinary shares of 10p each ("Ordinary Shares") in the Company.

The Company was notified on 23 September 2009 that Andrew Newland purchased in aggregate 200,000 Ordinary Shares in ANGLE at a price of 15.25 pence per share on 23 September 2009, representing 0.74% of the Company's current issued share capital. Following the purchase, Andrew Newland is beneficially interested in 7,054,686 Ordinary Shares, representing 26.00% of the Company's issued share capital.

For further information:

Notes to Editors

ANGLE plc 

Founded in 1994, ANGLE is an international venture management company focusing on the commercialisation of technology and the development of technology-based industry. ANGLE creates, develops and advises technology businesses on its own behalf and for its clients.

ANGLE's specialist Management services business provides support on a fee-for-service basis to major clients around the world involved in incubation, IP commercialisation, SME innovation and growth and the operation of science & technology parks.

ANGLE also owns a portfolio of companies with high growth potential in the medical and technology sectors in both the UK and the US. These have been developed whilst subsidiaries of ANGLE using its proprietary Progeny® process. ANGLE seeks to retain a substantial shareholding in these companies with a view to ongoing returns from dividend, milestone, royalty and capital returns.

ANGLE's venture management and technology commercialisation skills are of increasing relevance as global economies focus on regeneration, innovation and value added components to their industries. ANGLE's technology skills in IT and software, medical and life sciences, clean tech and renewable energies are directly relevant to major growth markets of the future and are marketed as specialised Management services.

ANGLE is quoted on AIM (AGL.L); further information can be found on www.ANGLEplc.com